1,852.22 → 1,770.22 shares held−4% of their stake
Labcorp's SVP, Chief Accounting Officer sold $25K of Labcorp shares. Nobody planned it ahead of time.
Traded Jul 2, 2026 · Filed Jul 6, 2026
Labcorp's Chief Legal Officer sold $26K of Labcorp shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$26,329
Shares × reported transaction price
63 days after results of Apr 30, 2026, 28 days before results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $286.98 on Jul 2, 2026, within 2% of its 52-week high, after a 13% rise over the previous 30 trading days
52-week range $243.04 (Jul 21, 2025) to $290.93 (Oct 20, 2025), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $253.69 on May 19, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.9% | +0.6% | -3.4% |
| 30 days | +11.5% | +2.8% | +8.7% |
Past results only. Not a forecast.
1,852.22 → 1,770.22 shares held−4% of their stake
Labcorp's SVP, Chief Accounting Officer sold $25K of Labcorp shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
3,108.22 → 1,770.22 shares held−43% of their stake
Labcorp's SVP, Chief Accounting Officer sold $414K of Labcorp shares. Nobody planned it ahead of time.